Corporate Banner
Satellite Banner
Technology Networks Header
Monday, December 22, 2014
 
Register | Sign in
Home Page>Products
  Product News
Quest Diagnostics Introduces BRCAvantage Plus™
Friday, November 07, 2014
First major service extension to the company's BRCAvantage™ BRCA1 and BRCA2 mutation test menu offers screening for five new non-BRCA genes shown to increase risk of inherited breast cancer.

Merck Millipore's New SNAP i.d.® 2.0 System for Immunohistochemistry
Friday, November 07, 2014
Offers parallel processing of up to 24 slides at once, without the cost of automation.

Top Ten Pharma Uses Time Saving Fill-it System in Biologics Manufacturing
Friday, November 07, 2014
To assure consistent quality cell banks and reference standards at half the cost.

EKF Molecular to Exhibit at AMP 2014
Friday, November 07, 2014
Senior executives on hand to discuss collaborative research with MGH aimed at developing routine blood based tests for cancer.

Merck Millipore's Guava easyCyte™ 12 Flow Cytometer
Friday, November 07, 2014
Increased performance provides better sensitivity and resolution.

Simple and Reliable Determination of Acesulfame in Vinegar
Friday, November 07, 2014
Detection of acesulfame using the Thermo Scientific™ Acclaim™ Mixed-Mode WAX-1 column.

Immersion Coolers for Flexible Cooling Down to -100 °C
Friday, November 07, 2014
A flexible solution for a variety of cooling applications.

AB SCIEX Expands Software Capability To Include DiscoveryQuantTM 3.0 Software
Thursday, November 06, 2014
DiscoveryQuant 3.0 Software increases efficiency for data analysis in high throughput drug discovery laboratory for all molecule types.

Collaboration Between SCIENION and GENOMICA
Wednesday, November 05, 2014
Collaboration results in a novel multiplex based detection kit for the identification and specific differentiation of 18 microorganism causing STIs.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 10725
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn